Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02085941 · ClinicalTrials.gov registry record · NA
Image-guided Cryoablation of Head, Neck and Spine Tumors
A NA study of Head and Neck Neoplasms and Malignant Neoplasm of Vertebral Column, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 2
- Study locations
NCT02085941 is a NA study of Head and Neck Neoplasms and Malignant Neoplasm of Vertebral Column that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 30 participants, below the 264-participant average among 23 other Head and Neck Neoplasms trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT02085941, a NA study of Head and Neck Neoplasms and Malignant Neoplasm of Vertebral Column, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
This research study is evaluating a procedure called cryoablation (the removal of diseased tissue using extreme freezing temperatures) as a possible treatment for head, neck and spine tumors.
Conditions Studied
Interventions
- DEVICE Cryoablation
- DEVICE Biopsy
Study Locations (2)
Massachusetts
- Brigham and Women's Hospital - Boston
- Dana Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2015-02 |
| Est. Completion | 2021-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02085941
The ClinicalTrials.gov registry entry for NCT02085941 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 264-participant average among 23 other Head and Neck Neoplasms trials with a reported enrollment target (89% lower). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Head and Neck Neoplasms appearing as the primary indexed condition, and to 2 interventions - of which Cryoablation is the first listed.
NCT02085941 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02085941 about?
NCT02085941 is a clinical study titled "Image-guided Cryoablation of Head, Neck and Spine Tumors". This research study is evaluating a procedure called cryoablation (the removal of diseased tissue using extreme freezing temperatures) as a possible treatment for head, neck and spine tumors.
What is the current status of trial NCT02085941?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2015-02. Estimated completion is 2021-07.
What conditions does trial NCT02085941 study?
This clinical trial studies the following conditions: Head and Neck Neoplasms, Malignant Neoplasm of Vertebral Column.
What interventions are being tested in trial NCT02085941?
The interventions under investigation include: Cryoablation (DEVICE), Biopsy (DEVICE).
Who is sponsoring clinical trial NCT02085941?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02085941 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head and Neck Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
EMST in Patients Undergoing CRT for HNCA
RECRUITING · NA
-
The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads
RECRUITING · NA
-
Head and Neck Cancer Study Project in the Geriatric Population
RECRUITING · Phase 3
-
NIDCD Otolaryngology Clinical Protocol Biospecimen Bank
RECRUITING
-
A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
RECRUITING · Phase 2
-
Molecular and Genomic Profiling of Head and Neck Tumors
RECRUITING
Explore more on PlainTrial
Head and Neck Neoplasms
All registered trials for this condition
Malignant Neoplasm of Vertebral Column
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.